E-Cigarette Nicotine Delivery Could Surpass Current NRTs’ Efficacy – FDA
This article was originally published in The Tan Sheet
Executive Summary
Nicotine replacement therapies have “helped millions of smokers quit, but it’s a lot slower rate of delivery. They’re safe and effective, but should we also be looking at the speed of delivery as well?” FDA tobacco regulation chief Mitch Zeller posits.
You may also be interested in...
Turning Back Calendar Could Keep E-Cigarettes Available Without Approval
Exercising enforcement discretion concerning the grandfather date for e-cigarettes and other products covered in FDA’s proposed deeming rule would not be the agency’s first use of the enforcement tool in implementing Tobacco Control Act regulations.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.